GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mach7 Technologies Ltd (ASX:M7T) » Definitions » Long-Term Capital Lease Obligation

Mach7 Technologies (ASX:M7T) Long-Term Capital Lease Obligation : A$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Mach7 Technologies Long-Term Capital Lease Obligation?

Mach7 Technologies's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.00 Mil.

Mach7 Technologies's quarterly Long-Term Capital Lease Obligation increased from Dec. 2022 (A$0.00 Mil) to Jun. 2023 (A$0.99 Mil) but then declined from Jun. 2023 (A$0.99 Mil) to Dec. 2023 (A$0.00 Mil).

Mach7 Technologies's annual Long-Term Capital Lease Obligation increased from Jun. 2021 (A$0.80 Mil) to Jun. 2022 (A$1.14 Mil) but then declined from Jun. 2022 (A$1.14 Mil) to Jun. 2023 (A$0.99 Mil).


Mach7 Technologies Long-Term Capital Lease Obligation Historical Data

The historical data trend for Mach7 Technologies's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mach7 Technologies Long-Term Capital Lease Obligation Chart

Mach7 Technologies Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.19 0.80 1.14 0.99

Mach7 Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.14 - 0.99 -

Mach7 Technologies  (ASX:M7T) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Mach7 Technologies Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Mach7 Technologies's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Mach7 Technologies (ASX:M7T) Business Description

Traded in Other Exchanges
N/A
Address
120 Kimball Avenue, Suite 210, South Burlington, VT, USA, 05403
Mach7 Technologies Ltd is engaged in enterprise imaging data sharing, storage, and interoperability for healthcare enterprises globally. The principal activity of the Company is the development and commercialisation of medical imaging and data, management software solutions for global healthcare enterprises The company's operating segment includes Software licenses and Professional services. It generates maximum revenue from the Software licenses segment. Geographically, it derives a majority of its revenue from North America and also has a presence in the Middle East; Asia/Pacific and Europe, and other regions. The company's solutions include Management Studio; Diagnostic Studio; and Clinical Studio.

Mach7 Technologies (ASX:M7T) Headlines

No Headlines